Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
This article is a starting point for education, not a guide to self-treatment
By documenting every step, sourcing high-quality materials, and adhering to strict safety standards, you can achieve consistent and compliant research results
Ipamorelin Best for: growth-hormone axis stimulation for lean mass and recovery support Ipamorelin is a synthetic pentapeptide (amino acid sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2) that belongs to the growth hormone secretagogue class, acting as a selective agonist at the ghrelin receptor (GHS-R1a) in the pituitary gland to stimulate pulsatile growth hormone release
Suaste V et al
Main human AOD-9604 treatment timelines Study METAOD004 Participants 36 Route Oral Treatment length 7 days Dose range 9, 27, or 54 mg/day Main lesson Short safety and tolerability study Study METAOD005 Participants 300 Route Oral Treatment length 12 weeks Dose range 1 to 30 mg/day Main lesson Earlier weight-loss trial with a non-linear dose response Study METAOD006 Participants 502 randomized Route Oral Treatment length 24 weeks Dose range 0.25, 0.5, or 1 mg/day Main lesson Primary weight-loss goal was not met The oral milligram doses in these trials cannot be converted into subcutaneous microgram doses
Vitamin B12 deficiency in over 16s: diagnosis and management (NG239) Recommendations
